Cue Health Inc. (HLTH)

Exchange NASDAQ
3.76


Currency in USD (Disclaimer)
Volume:
Day's Range:

HLTH Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-06 Sever Clint officer: Chief Product Officer 4,010,936.0 F-InKind D 10,633.0 5.30 56,354.90
2022-06-06 Palsis Erica officer: General Counsel 669,496.0 F-InKind D 5,948.0 5.30 31,524.40
2022-06-06 Khattak Ayub K director, officer: President and CEO 12,117,258 F-InKind D 12,996.0 5.30 68,878.80
2022-06-06 Gallagher John E officer: Chief Financial Officer 681,699.0 F-InKind D 7,548.0 5.30 40,004.40
2022-06-06 Achar Christopher K director 1,593,264.0 F-InKind D 4,327.0 5.30 22,933.10
2022-03-30 Achar Christopher K director 1,597,591.0 A-Award A 139,635.0 0.00 0.00
2022-03-30 Gallagher John E officer: Chief Financial Officer 689,247.0 A-Award A 236,090.0 0.00 0.00
2022-03-30 Sever Clint officer: Chief Product Officer 4,021,569.0 F-InKind D 99,772.0 6.70 668,472.40
2022-03-30 Sever Clint officer: Chief Product Officer 4,121,341.0 A-Award A 239,591.0 6.70 1,605,259.70
2022-03-30 Sever Clint officer: Chief Product Officer 3,881,750.0 A-Award A 343,130.0 0.00 0.00
2022-03-30 Palsis Erica officer: General Counsel 675,444.0 A-Award A 214,812.0 0.00 0.00
2022-03-30 Khattak Ayub K director, officer: President and CEO 12,130,254 F-InKind D 126,963.0 6.70 850,652.10
2022-03-30 Khattak Ayub K director, officer: President and CEO 12,257,217 A-Award A 292,833.0 6.70 1,961,981.10
2022-03-30 Khattak Ayub K director, officer: President and CEO 11,964,384 A-Award A 419,382.0 0.00 0.00
2022-03-28 Gallagher John E officer: Chief Financial Officer 453,157.0 F-InKind D 12,511.0 6.99 87,451.89
2022-03-24 Sever Clint officer: Chief Product Officer 3,538,620.0 F-InKind D 34,754.0 6.99 242,930.46
2022-03-24 Khattak Ayub K director, officer: President and CEO 11,545,002 F-InKind D 42,264.0 6.99 295,425.36
2022-02-01 Palsis Erica officer: General Counsel 460,632.0 F-InKind D 38,912.0 8.78 341,647.36
2021-12-28 Gallagher John E officer: Chief Financial Officer 465,668.0 F-InKind D 17,452.0 15.66 273,298.32
2021-09-28 Achar Christopher K director 0.0 C-Conversion D 69,710.0 0.00 0.00
2021-09-28 Achar Christopher K director 1,457,956.0 C-Conversion A 69,710.0 0.00 0.00
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 5,491,741.0 J-Other A 371,293.0 12.80 4,752,550.40
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 5,120,448.0 C-Conversion A 4,926,417.0 0.00 0.00
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 9,748,805.0 C-Conversion A 9,619,451.0 0.00 0.00
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Sherpa Ventures Fund, LP 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Cui Xiangmin director 0.0 C-Conversion D 8,192,468.0 0.00 0.00
2021-09-28 Cui Xiangmin director 788,441.0 A-Award A 788,441.0 12.80 10,092,044.80
2021-09-28 Cui Xiangmin director 8,192,468.0 C-Conversion A 8,192,468.0 0.00 0.00
2021-09-28 Cove Investors I, LLC 10 percent owner 0.0 C-Conversion D 273,082.0 0.00 0.00
2021-09-28 Cove Investors I, LLC 10 percent owner 0.0 C-Conversion D 273,082.0 0.00 0.00
2021-09-28 Cove Investors I, LLC 10 percent owner 0.0 C-Conversion D 273,082.0 0.00 0.00
2021-09-28 Cove Investors I, LLC 10 percent owner 12,377,254 C-Conversion A 6,721,714.0 0.00 0.00
2021-09-28 Section 32 Fund 2, LP 10 percent owner 0.0 C-Conversion D 3,485,535.0 0.00 0.00
2021-09-28 Section 32 Fund 2, LP 10 percent owner 3,485,535.0 C-Conversion A 3,485,535.0 0.00 0.00
2021-09-28 Stanford Scott director, 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Stanford Scott director, 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Stanford Scott director, 10 percent owner 0.0 C-Conversion D 1,092,329.0 0.00 0.00
2021-09-28 Stanford Scott director, 10 percent owner 5,491,741.0 A-Award A 371,293.0 12.80 4,752,550.40
2021-09-28 Stanford Scott director, 10 percent owner 5,120,448.0 C-Conversion A 4,926,417.0 0.00 0.00
2021-09-28 Stanford Scott director, 10 percent owner 9,748,805.0 C-Conversion A 9,619,451.0 0.00 0.00
2021-09-28 Decheng Capital China Life Sciences USD Fund III, L.P. 10 percent owner 0.0 C-Conversion D 8,192,468.0 0.00 0.00
2021-09-28 Decheng Capital China Life Sciences USD Fund III, L.P. 10 percent owner 8,192,468.0 C-Conversion A 8,192,468.0 0.00 0.00
2021-09-28 Gallagher John E officer: Chief Financial Officer 483,120.0 F-InKind D 66,379.0 18.63 1,236,640.77
2021-09-24 Faig Carole T director 18,750.0 A-Award A 18,750.0 0.00 0.00
2021-09-24 Martinez Maria director 18,750.0 A-Award A 18,750.0 0.00 0.00
2021-09-24 Khattak Ayub K director, officer: President and CEO 11,587,266 A-Award A 976,111.0 0.00 0.00
2021-09-24 Bradford K Joanne director 18,750.0 A-Award A 18,750.0 0.00 0.00
2021-09-24 Sever Clint officer: Chief Product Officer 3,573,374.0 A-Award A 798,636.0 0.00 0.00
2021-09-24 Achar Christopher K director 1,388,246.0 A-Award A 1,388,246.0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.